N-[3-(3-DIMETHYLAMINO-PROPYLAMINO)-PROPYL]-ISONICOTINAMIDE
![N-[3-(3-DIMETHYLAMINO-PROPYLAMINO)-PROPYL]-ISONICOTINAMIDE price.](/StructureFile/ChemBookStructure5/GIF/CB7199215.gif)
|
- $378 - $874
- Product name: N-[3-(3-DIMETHYLAMINO-PROPYLAMINO)-PROPYL]-ISONICOTINAMIDE
- CAS: 402777-69-9
- MF: C14H24N4O
- MW: 264.37
- EINECS:
- MDL Number:MFCD02735621
- Synonyms:N-[3-(3-DIMETHYLAMINO-PROPYLAMINO)-PROPYL]-ISONICOTINAMIDE;4-Pyridinecarboxamide, N-[3-[[3-(dimethylamino)propyl]amino]propyl]-
3 prices
Selected condition：
Brand
- American Custom Chemicals Corporation
- Crysdot
- Matrix Scientific
Package
- 500MG
- 1g
- 5g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0091437
- Product descriptionN-[3-(3-DIMETHYLAMINO-PROPYLAMINO)-PROPYL]-ISONICOTINAMIDE 95.00%
- Packaging500MG
- Price$762.3
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11128738
- Product descriptionN-(3-((3-(Dimethylamino)propyl)amino)propyl)isonicotinamide 97%
- Packaging5g
- Price$874
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number008294
- Product descriptionN-[3-(3-Dimethylamino-propylamino)-propyl]-isonicotinamide
- Packaging1g
- Price$378
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| American Custom Chemicals Corporation | CHM0091437 | N-[3-(3-DIMETHYLAMINO-PROPYLAMINO)-PROPYL]-ISONICOTINAMIDE 95.00% | 500MG | $762.3 | 2021-12-16 | Buy |
| Crysdot | CD11128738 | N-(3-((3-(Dimethylamino)propyl)amino)propyl)isonicotinamide 97% | 5g | $874 | 2021-12-16 | Buy |
| Matrix Scientific | 008294 | N-[3-(3-Dimethylamino-propylamino)-propyl]-isonicotinamide | 1g | $378 | 2021-12-16 | Buy |
Properties
Boiling point :466.9±35.0 °C(Predicted)
Density :1.038±0.06 g/cm3(Predicted)
pka :13.42±0.46(Predicted)
Density :1.038±0.06 g/cm3(Predicted)
pka :13.42±0.46(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|